|
CAMK1D expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.74682490694522E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.93611793264381E-12 |
| Normal-vs-Stage2 |
1.28600463611406E-11 |
| Normal-vs-Stage3 |
1.63702384980979E-12 |
| Normal-vs-Stage4 |
5.44009282066327E-15 |
| Stage1-vs-Stage2 |
5.610600E-01 |
| Stage1-vs-Stage3 |
2.100400E-02 |
| Stage1-vs-Stage4 |
1.965990E-02 |
| Stage2-vs-Stage3 |
7.434000E-02 |
| Stage2-vs-Stage4 |
4.163800E-02 |
| Stage3-vs-Stage4 |
5.933600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.85167461761193E-14 |
| Normal-vs-AfricanAmerican |
2.25630625294571E-12 |
| Normal-vs-Asian |
1.02695629777827E-13 |
| Caucasian-vs-AfricanAmerican |
7.025600E-01 |
| Caucasian-vs-Asian |
7.921800E-01 |
| AfricanAmerican-vs-Asian |
8.560400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.66644475996236E-12 |
| Normal-vs-Female |
1.82298620643451E-13 |
| Male-vs-Female |
2.550400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.84141590864328E-12 |
| Normal-vs-Age(41-60Yrs) |
1.6832091276342E-12 |
| Normal-vs-Age(61-80Yrs) |
1.72339920112563E-12 |
| Normal-vs-Age(81-100Yrs) |
6.63520000054874E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.052400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.763200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.562600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.732000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.297600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.230000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.020100E-03 |
| Classical-VS-Follicular |
5.619000E-03 |
| Classical-VS-Other |
2.761000E-01 |
| Classical-VS-Normal |
1.46549439250521E-13 |
| Tall-VS-Follicular |
9.79169999999474E-05 |
| Tall-VS-Other |
7.989400E-01 |
| Tall-VS-Normal |
1.88737914186277E-15 |
| Follicular-VS-Other |
1.162050E-01 |
| Follicular-VS-Normal |
5.83459947023357E-11 |
| Other-VS-Normal |
3.39249961456289E-10 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.36983782492462E-13 |
| Normal-vs-N1 |
1.4432899320127E-15 |
| N0-vs-N1 |
1.161320E-04 |
|
|
